Metabolic syndrome in Tunisian bipolar I patients

African Health Sciences

Volumn 11, Issue 3, 2011, Pages 414-420

  Ezzaher, A ^a   Haj Mouhamed, D ^a   Mechri, A ^a   Neffati, F ^a   Douki, W ^a   Gaha, L ^a   Najjar, M F ^a  

^a University Hospital of Monastir   (Tunisia)

Author keywords

Bipolar disorder; Insulin resistance; Metabolic syndrome; Uric acid

Indexed keywords

CARBAMAZEPINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LITHIUM SALT; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; URIC ACID; VALPROIC ACID; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BIPOLAR I DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; DSM-IV; ETHNIC GROUP; FEMALE; GENDER; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; TUNISIAN; BIPOLAR DISORDER; BLOOD; TUNISIA;

ADULT; BIPOLAR DISORDER; CHOLESTEROL, HDL; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; TRIGLYCERIDES; TUNISIA;

EID: 84861307396     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62: 593-602.
2. Revicki DA, Matza LS, Flood E, Lloyd A. Bipolar disorder and health-related quality of life: review of burden of disease and clinical trials. Pharmacoeconomics. 2005; 23 (6): 583-594.
3. Wyatt RJ, Henter I, Leary MC, Taylor E. An economic evaluation of manicdepressive illness: 1991. Soc Psychiatry Psychiatr Epidemiol. 1995; 30: 213-219.
4. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003; 64(2): 161-174.
5. Sicras A, Rejas J, Navarro R, Serrat J, Blanca M. Metabolic syndrome in bipolar disorder: a crosssectional assessment of a Health Management Organization database. Bipolar Disord.2008; 10: 1-10.
6. Cardenas J, Frye MA, Marusak SL, Levander EM, Chirichigno JW, Lewis S, et al. Modal subcomponents of metabolic syndrome in patients with bipolar disorder. J Affect Disord. 2008; 106: 91-97.
7. Van Winkel R, De Hert M, Van Eyck D, Hanssens L, Wampers M, Scheen, et al. Prevalence of diabetes and the metabolic syndrome in a sample patients with bipolar disorder. Bipolar Disord. 2008; 10:342-348.
8. Salvi V, Albert U, Chiarle A, Soreca I, Bogetto F, Maina G. Metabolic syndrome in Italian patients with bipolar disorder. Gen Hosp Psych. 2008; 30: 318-323.
9. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder: findings from the bipolar disorder center for Pennsylvanians. Bipolar Disord. 2005; 7: 424-430.
10. Bermudes RA, Keck PE, Welge JA. The prevalence of the metabolic syndrome in psychiatric inpatients with primary psychotic and mood disorders. Psychosomatics. 2006; 47: 491-497.
11. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington DC, USA: American Psychiatric Association; 2004.
12. National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002; 106: 3143-421.
13. Ozdemir A, Yalinbas B, Selamet U, Eres M, Turkmen F, Kumbasar F, et al. The effect of hepatitis C virus infection on insulin resistance in chronic haemodialysis patients. Yonsei Med J. 2007; 48: 274-280.
14. Bouguerra R, Ben Salem L, Alberti H, Ben Rayana C, El Atti J, Blouza S, et al. Prevalence of metabolic abnormalities in the Tunisian adults: a population based study. Diabetes Metab. 2006; 32: 215-221.
15. Garcia-Portilla MP, Saiz PA, Benabarre A, Sierra P, Perez J, Rodriguez A, et al. The prevalence of metabolic syndrome in patients with bipolar disorder. J Affect Disord. 2008; 106: 197-201.
16. Ezzaher A, Haj Mouhamed D, Mechri A, Neffati F, Douki W, Gaha L, et al. Obesity and dyslipidemia in Tunisian bipolar subjects. Ann Biol Clin. 2010; 68: 277-284.
17. Yumru M, Savas HA, Kurt E, Kaya MC, Salek S, Savas E, et al. Atypical antipsychotics related metabolic syndrome in bipolar patients. J Affect Disord. 2007; 98: 247-252.
18. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet. 1992; 339: 1128-1130.
19. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M. Association between white blood cell count and carotid arteriosclerosis in Japanese smokers. Atherosclerosis. 2004; 175: 95-100.
20. Moon YS, Kim DH, Song DK. Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents. Metabolism. 2004; 53: 863-867.
21. Miyazaki T, Shimada K, Mokuno H, Daida H. Adipocyte derived plasma protein, adiponectin, is associated with smoking status in patients with coronary artery disease. Heart. 2003; 89: 663
22. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004; 24: 29-33.
23. Alkerwi A, Boutsen M, Vaillant M, Barre J, Lair ML, Albert A, et al. Alcohol consumption and the prevalence of metabolic syndrome: A meta analysis of observational studies. Atherosclerosis.2009; 204: 624-635.
24. Murray DP, Weiner M, Prabhakar M, Fiedorowicz JG. Mania and mortality: why the excess cardiovascular risk in bipolar disorder? Curr Psychiatr Rep. 2009; 11: 475-480.
25. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord. 2002; 68: 167-181.
26. Casey DE. Metabolic issues and cardiovascular disease in patients with psychiatric disorders. Am J Med. 2005; 118: 15S-22S.
27. Toalson P, Ahmed S, Hardy T, Kabinoff G. The metabolic syndrome in patients with severe mental illnesses. Prim Care Companion J Clin Psychiatry. 2004; 6: 152-158.
28. Vuorinen-Markkola H, Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab. 1994; 78: 25-29.
29. Chien KL, Hsub HC, Lee YT, Chen MF. Renal function and metabolic syndrome components on cardiovascular and all-cause mortality. Atherosclerosis. 2008; 197: 860-867.
30. Fromenty B, Robin MA, Igoudjil A, Mansouri A, Pessayre D. The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab. 2004; 30: 121-138.